Preliminary findings indicate that key sex differences in diabetic retinopathy disease presentation could be essential for precision diagnostics. Sex differences could play a key role in diagnosing diabetic retinopathy, according… Read More
RANKLIN LAKES, NJ – BD, a leading global medical technology company, announced a significant milestone in its advanced tissue regeneration strategy: the first Phasix™ Mesh laparotomy reinforcement case performed in… Read More
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 in patients with IgA nephropathy expected to… Read More
New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition age Brigham and… Read More
Richmond, BC — SignalChem Lifesciences Corp announced the publication of first-in-human Phase 1 clinical trial results for SLC-391, its novel, orally bioavailable and selective AXL inhibitor, in the peer-reviewed journal… Read More
